News

June 8, 2022

What Are Rebound Headaches and How Can You Cope?

If you’re one of the 1 million people in Washington state who experience headaches, there’s a fair chance you reach for a painkiller at the first sign of throbbing or radiating pain. This makes sense: Many pain medications say headache or migraine relief right on the bottle. But most pain medications weren’t specifically designed to…

June 1, 2022

Two Pacific Northwest Women Share Their MS Stories

There are a lot of stereotypes out there about multiple sclerosis (MS), a chronic disease that can lead to vision loss, trouble walking and muscle weakness. But did you know that, despite how serious it can be, it’s possible to live a full life with it?… Read the full article on Right as Rain, featuring…

May 29, 2022

Gene Therapy Shows Promise for DMD, as Trials Continue and Challenges Remain

UW Neurology’s Jeffrey Chamberlain, PhD, outlined the 4 different types of gene therapy for treating Duchenne muscular dystrophy (DMD) at the Gene Therapy and Gene Editing Symposium which took place on the second day of the CureDuchenne 2022 FUTURES National Conference. Dr. Chamberlain is a professor at the University of Washington School of Medicine and director of the…

May 28, 2022

Stroke survivor’s journey a reminder to know warning signs

May is National Stroke Awareness Month. This time of year has a renewed meaning for Dorene Centioli-McTigue. The founder of Pagliacci Pizza at first did not recognize a subtle stroke warning sign a year ago. Now she encourages others to learn the signs and seek help immediately if they experience any of the symptoms…

April 28, 2022

Congratulations to Dr. Cyrus Zabetian

Dr. Cyrus Zabetian has received over $1.2 million in funding for his study: Genetic Movement Disorders: Etiologies and PathogenesesThe major goal of this project is to identify the molecular etiologies of genetic movement disorders as an important step towards improving diagnoses, elucidating pathogeneses, and facilitating efforts to develop targeted therapies.

Congratulations to Dr. Chris Ransom for his VA Clinician Scientist Investigator Award

VA BLR&D Program Officials can nominate one fundable grant from their panels each cycle. Dr. Chris Ransom was nominated and received the Award for his research: “Regulation of extrasynaptic GABA-A receptors in health and disease”This project will study cellular and molecular changes that occur after experiment TBI, with focus on extrasynaptic GABA receptors (both GABA-A…

April 22, 2022

Act FAST – Seattle Fire Station 28 EMS Team Outreach

Knowing the signs and symptoms of stroke and acting FAST is crucial when it comes to stroke care. Our EMS partners are the first responders to the community play an key part in this care. UW Medicine Stroke Team members Dr. David Tirschwell, Kelsey Hagstrand, ARNP and Kelly Bender Outreach Liaison met with Seattle Fire…

April 21, 2022

Congratulations to the UW Regional Epilepsy Center!

The UW Regional Epilepsy Center has been re-credentialed by the National Association of Epilepsy Centers as a NAEC Level 4 Center for 2022 and 2023. This is their highest-level designation and certifies that our Center is capable of handling the most complicated surgical epilepsy cases.

March 1, 2022

UW Medicine MS Walk – April 24, 2022

Brain Awareness Week 2022

Wednesday, March 9, 2022
4:00-5:00pm PST

Alzheimer’s disease is a common form of dementia that leads to devastating cognitive and neurological deficits. However, despite affecting an estimated 6.2 million adults in the US alone in 2021, its causes are poorly understood and no effective treatments exist to halt or reverse the neuron death caused by the disease. How the disease starts — and what happens in single cells across the brain as the disease progresses — is similarly unknown. Research at the Allen Institute for Brain Science and elsewhere on the types of cells that make up the human brain has applications for understanding what is happening in Alzheimer’s.

Previous page Next page